SCHEMBL1490684

SCHEMBL1490684

COC(=O)c1c(NC(=O)OCc2ccccc2)csc1-c1ccc(C)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
MMP12 P39900 3/20 0.49
HDAC3 O15379 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC2 Q92769 1/20 0.48
MAPT P10636 3/20 0.46
LMNA P02545 2/20 0.46
POLB P06746 2/20 0.46
ALDH1A1 P00352 2/20 0.44
HTT P42858 1/20 0.44
KMT2A Q03164 1/20 0.44
MMP13 P45452 1/20 0.42
MAPK1 P28482 2/20 0.42
TRPV1 Q8NER1 1/20 0.42
PTPN1 P18031 1/20 0.42
CASP3 P42574 2/20 0.42
MGLL Q99685 1/20 0.42
TSHR P16473 1/20 0.42
HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1490651 0.90 NPC1 (0.48) NPC1RAB9AHDAC3HDAC1HDAC2
SCHEMBL1490425 0.90 RAB9A (0.48) NPC1RAB9AHDAC3HDAC1HDAC2
SCHEMBL1490594 0.90 MGLL (0.52) NPC1RAB9AHDAC3HDAC1HDAC2
SCHEMBL3555247 0.85 NPC1 (0.58) NPC1RAB9AHDAC3HDAC1HDAC2
SCHEMBL1490620 0.84 RAB9A (0.47) NPC1RAB9AMMP12HDAC3HDAC1
SCHEMBL1490577 0.84 HDAC3 (0.45) NPC1RAB9AHDAC3HDAC1HDAC2
SCHEMBL1490217 0.82 NPC1 (0.52) NPC1RAB9AHDAC3HDAC1HDAC2
SCHEMBL1490720 0.80 NPC1 (0.50) NPC1RAB9AHDAC3HDAC1HDAC2
SCHEMBL12756642 0.80 HDAC3 (0.50) NPC1RAB9AHDAC3HDAC1HDAC2
SCHEMBL1491014 0.80 HDAC3 (0.50) NPC1RAB9AHDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 US disclosed
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 US disclosed
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 US disclosed
US-8618307-B2 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2013-12-31 US disclosed
EP-2477982-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM Calcimedica, Inc. (US) 2012-07-25 EP disclosed
WO-2011034962-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2011-03-24 WO disclosed
WO-2011034962-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2011-03-24 WO disclosed
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-03-17 US disclosed
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 NPC1 262/4885RAB9A 1174/4885MMP12 3483/4885
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 NPC1 262/4885RAB9A 1174/4885MMP12 3483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.